Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis

This study has been completed.
Sponsor:
Collaborator:
Centocor, Inc.
Information provided by (Responsible Party):
University of Arizona
ClinicalTrials.gov Identifier:
NCT00796809
First received: November 21, 2008
Last updated: December 11, 2015
Last verified: December 2015
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: October 2008
  Primary Completion Date: June 2008 (Final data collection date for primary outcome measure)